|
Research Management and Support
|
RMS2009 [E]
|
$350,982,837
|
$489,000
|
N/A
|
National Cancer Institute
|
|
Infections, immunity, and inflammation in cancer
|
ZIA CP010150-10078
|
$600,005
|
$600,005
|
A Engels, Eric
|
DCEG (NCI)
|
|
Family Studies
|
ZIA CP004410-08167
|
$160,190
|
$8,010
|
A Tucker, Margaret
|
DCEG (NCI)
|
|
Family Studies
|
ZIA CP004410-08300
|
$691,498
|
$691,498
|
A Tucker, Margaret
|
DCEG (NCI)
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-06
|
$238,147
|
$2,381
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$774,176
|
$77,418
|
Alavanja
|
DCEG (NCI)
|
|
Corn Farming Study
|
ZIA CP010119-02075
|
$10,378
|
$7,265
|
Alavanja
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$804,186
|
$80,419
|
Albanes
|
DCEG (NCI)
|
|
Vitamin D Pooling Project
|
ZIA CP010195-10436
|
$398,953
|
$67,822
|
Albanes
|
DCEG (NCI)
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-10
|
|
$0
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
SPORE in Lymphoma
|
3P50CA096888-05S2
|
$304,005
|
$76,001
|
AMBINDER, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$72,809
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biologic Therapy for B-cell non-Hodgkin's Lymphoma
|
5R01CA092104-06
|
$258,741
|
$258,741
|
ANSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mechanisms of GVHD
|
9P01CA142106-06A1
|
$1,953,263
|
$976,632
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
|
5K24CA128953-02
|
$164,476
|
$32,895
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$279,762
|
$41,964
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$279,762
|
$111,905
|
Aplan, Peter
|
CCR (NCI)
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$5,540,000
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$506,790
|
$101,358
|
Arthur, Diane
|
CCR (NCI)
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-23
|
$2,304,698
|
$46,094
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$1,309
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$4,174
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mid-Region AIDS and Cancer Specimen Resource Consortium
|
3U01CA066531-14S1
|
$223,528
|
$44,706
|
AYERS, LEONA
|
OHIO STATE UNIVERSITY
|
|
Mid-Region AIDS and Cancer Specimen Resource Consortium
|
5U01CA066531-14
|
$603,092
|
$120,618
|
AYERS, LEONA
|
OHIO STATE UNIVERSITY
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-19
|
$687,330
|
$6,873
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Southwest Oncology Group
|
5U10CA027057-30
|
$267,015
|
$13,351
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-30
|
$9,379,270
|
$468,964
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-25
|
$10,708,109
|
$321,243
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-05
|
$1,093,403
|
$109,340
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings
|
5R01CA121935-04
|
$248,486
|
$248,486
|
Barber, Glen
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Molecular Basis of Action of the Putative Oncogene BCL-6
|
5R01CA071540-12
|
$311,124
|
$311,124
|
BARDWELL, VIVIAN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Biomonitoring of Organochlorines
|
ZIA CP010121-02037
|
$74,400
|
$74,400
|
Baris
|
DCEG (NCI)
|
|
Kaiser NHL - Nested Case-Control Study
|
ZIA CP010121-02113
|
$2,458
|
$2,458
|
Baris
|
DCEG (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
2U10CA077440-12
|
$345,040
|
$13,802
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
|
5R01CA125195-03
|
$312,550
|
$312,550
|
BASSING, CRAIG
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Annual Primary CNS Lymphoma Collaborative Group Meeting
|
5R13CA124293-04
|
$5,000
|
$5,000
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$109,331
|
$27,333
|
Bates, Susan
|
CCR (NCI)
|
|
Translational Studies of the Histone Deacetylase Inhibitor Romidepsin
|
ZIA BC 010621
|
$601,321
|
$481,057
|
Bates, Susan
|
CCR (NCI)
|
|
Overcoming tumor cell resistance to apoptosis with a natural product, GCS-100
|
1R21CA139368-01
|
$203,280
|
$203,280
|
BAUM, LINDA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-25
|
$1,884,250
|
$18,843
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Development of cambinol analogues as antilymphoma agents
|
5R01CA129132-02
|
$365,200
|
$365,200
|
BEDALOV, ANTONIO
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-03
|
$507,986
|
$5,080
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Oncogenes and oncogenic microRNAs in chicken tumors
|
5R01CA124596-02
|
$335,272
|
$335,272
|
Beemon, Karen
|
JOHNS HOPKINS UNIVERSITY
|
|
Iowa Oncology Research Association
|
5U10CA035101-24
|
$865,544
|
$8,655
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Cancer prevention by indole-3-carbinol via modulation of the epigenome
|
1R21CA135523-01A2
|
$160,820
|
$160,820
|
Benninghoff, Abby
|
OREGON STATE UNIVERSITY
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-34
|
$460,085
|
$4,601
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$4,981
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$4,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$5,735
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$467,556
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Non Hodgkins Lymphoma for this search: $130,883,333
|